Background IgE autoantibodies are considered to be involved in the pathogenesis of bullous pemphigoid (BP), particularly inflammatory and erythematous phenotypes. Objectives To develop reliable enzyme-linked immunosorbent assays (ELISAs) for the detection of IgE autoantibodies to both BP180 and BP230 in BP sera, and to compare the ELISA results with clinical features. Methods We used commercially available IgG ELISAs to develop IgE ELISAs for both BP180 and BP230. To determine the influence of excess amounts of IgG autoantibodies, all normal and BP sera were tested before and after IgG adsorption. The results of the IgE ELISAs were statistically compared with various ELISAs and various clinical parameters, including our own severity scores and BP phenotypes. Results IgG adsorption generally showed no changes in sensitivity and specificity for IgE ELISAs, although slight cross-reactivity of anti-IgE secondary antibody to IgG and interference of excess amounts of IgG autoantibodies to IgE reactivity were suggested. IgE autoantibodies to BP180 were found in 21 of 36 BP sera and IgE autoantibodies to BP230 were found in 18 of 36 BP sera. The results of IgG and IgE ELISAs for both BP180 and BP230 were well correlated. IgG and IgE anti-BP180 antibodies correlated with disease activity but IgG and IgE anti-BP230 autoantibodies did not. IgE anti-BP230 autoantibodies correlated with nodular phenotype but not erythematous phenotype. Conclusions The results of this study indicated that IgE autoantibodies to both BP180 and BP230 are frequently detected in BP sera. IgE anti-BP180 autoantibodies seemed to be pathogenic, while an association between IgE autoantibodies and inflammatory BP phenotype was not indicated.
• This study confirms the frequent detection of IgE autoantibodies to BP180 and BP230. IgE autoantibodies to BP180 correlated with disease activity, and IgE anti-BP230 antibodies correlated with nodular phenotypes, while they were not correlated with the inflammatory erythematous phenotype.
What is the translational message?
• We have developed reliable IgE ELISAs for both BP180 and BP230, which can be used in clinical practice.
• This study suggests that titres of IgE anti-BP180 autoantibodies correlated with disease activity in BP and should be clinically useful for selecting the best treatment, particularly with regard to anti-IgE antibody therapy.
Bullous pemphigoid (BP) is characterized clinically by tense blisters on the entire body, and histopathological analysis reveals subepidermal blisters with eosinophilic infiltration. 1, 2 In addition, most patients with BP show clinically extensive urticarial erythemas with severe itching, an increase in eosinophils and IgE and histopathology showing various inflammatory changes. 3 Patients with BP show IgG antiepidermal basement membrane zone autoantibodies that react primarily with BP230 and BP180. 4 While major epitopes for IgG anti-BP180 autoantibodies reside within the extracellular BP180 NC16a domain, [5] [6] [7] IgG antibodies in BP sera react with various domains on the entire BP230 molecule. 8 BP180 is a transmembrane protein, and its pathogenic role has been well documented in animal model studies. 9, 10 In contrast, because BP230 is an intracytoplasmic protein, the pathogenic role of BP230 is questionable. However, a recent study identified a novel disease entity (anti-BP230-type BP), in which IgG anti-BP230 antibodies are the sole autoantibodies and may be pathogenic.
11
In addition to IgG autoantibodies, the relevance of IgE autoantibodies in pathogenicity in BP is also indicated. [12] [13] [14] Previous studies detected in vivo bound/circulating IgE autoantibodies in BP with positive ratios ranging from 22% to 100%. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] The majority of these studies used IgE enzymelinked immunosorbent assays (ELISAs) of BP180 recombinant protein (RP) with positive ratios ranging from 22% to 77%, [17] [18] [19] [20] [21] 24, 25, 27 indicating that there were not yet standardized methods for IgE ELISAs. There were only three studies that used an IgE BP230 ELISA. 15, 19, 20 Several studies reported a possible correlation of IgE anti-BP180 antibodies with BP disease activity. 15, 17, 20, 21, 24 In addition, omalizumab, a humanized monoclonal antibody to FceRI, was successfully used in treatments in refractory patients with BP. [28] [29] [30] These findings indicated a pathogenic role for IgE autoantibodies in BP. In contrast, another study showed no apparent correlation. 25 Thus, the pathogenic relevance of IgE autoantibodies in BP is still unclear, although it has been suggested that IgE autoantibodies may be involved in the possible mechanisms that lead to the development of BP skin lesions. In this study, to examine further the presence and pathogenic role of IgE autoantibodies in BP, we detected IgE antibodies to both BP180 and BP230 using our novel ELISAs and compared the results with various clinical parameters. To exclude the possibility of interference by IgG autoantibodies, we examined all normal and BP sera before and after IgG depletion. The results indicated that IgE antibodies to both BP180 and BP230 are frequently detected in BP, and titres of IgE anti-BP180 autoantibodies correlated with disease activity.
Materials and methods
Details relating to patient information and sera, clinical findings including our own criteria of disease severities and BP phenotypes, IgG adsorption method, IgG and IgE ELISAs of BP180 and BP230, sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting, ELISA for human IgG, receiver operating characteristic curve (ROC) analysis and statistical analyses are described in File S1 (see Supporting Information).
Results

Background and laboratory findings for patients with bullous pemphigoid
The 36 patients with BP in this study included eight men (22%) and 28 women (78%) with an average age of 63Á6 years (Table 1) . When sera were obtained at the initial (mean 1007Á65) ( Table 1) .
Severity scores in patients with bullous pemphigoid and bullous pemphigoid phenotypes
The means of severity scores 1 and 2 were 2Á11 and 1Á47, respectively ( Fig. 1 and Table 1 ). Of the 36 patients with BP, 12 had bullous phenotype, 10 erythematous phenotype and eight had bullous/erythematous phenotype ( Fig. 1 and Table 1 ). In addition, four patients were diagnosed with pemphigoid nodularis, and two patients were diagnosed with localized pemphigoid (Brunsting-Perry type and dyshidrosiform type).
Confirmation of adsorption of IgG from the sera
In both Oriole fluorescent protein staining and immunoblotting for human IgG for five representative BP sera, the protein bands corresponding to nonreduced IgG, which were seen in comparable intensities in both preadsorbed sera and captured IgG samples, were extensively reduced in postadsorbed sera ( Fig. S1a,  b ; see Supporting Information). Human IgG ELISA also showed the reduction of IgG in the 36 BP sera and eight normal sera to undetectable levels after IgG adsorption ( Fig. S1c ; see Supporting Information). These results indicated that IgG adsorption could deplete IgG in sera almost completely.
Determination of cut-off values for various enzyme-linked immunosorbent assays in this study
In this study, cut-off index values for IgG ELISAs of BP180 and BP230 were calculated to be 10Á120 and 17Á960, respectively, based on the results of 36 preadsorbed normal sera (Table 1 and Table S1 ; see Supporting Information). These cut-off values were used for both preadsorbed and postadsorbed BP sera because postadsorbed normal sera showed extremely low indices. The cut-off OD450 values for IgE ELISAs of BP180 for postadsorbed and preadsorbed sera were 0Á030 and 0Á026, respectively, and the cut-off OD450 values for IgE ELISAs of BP230 for postadsorbed and preadsorbed sera were 0Á028 and 0Á034, respectively (Table 1 and  Table S1 ; see Supporting Information). We also examined the sera of 10 patients with atopic dermatitis, which had high total IgE levels. This examination showed no positive results in either of the IgE ELISAs. The results in IgG enzyme-linked immunosorbent assays of BP180 and BP230
In the IgG BP180 ELISA, all of the 36 preadsorbed BP sera showed positive results with relatively high indices, whereas only eight sera showed positive reactivity with much reduced indices after IgG adsorption (Fig. 2a , Table 1 and Table S2 ; see Supporting Information). In the IgG BP230 ELISA, 22 of the preadsorbed BP sera showed positive results with relatively high indices, which became negative after IgG adsorption, except for one serum (Fig. 2c , Table 1 and Table S2 ; see Supporting Information). These results provided further confirmation of the extensive removal of IgG antibodies after the IgG adsorption procedure.
The results in novel IgE enzyme-linked immunosorbent assays of BP180 and BP230
In the IgE BP180 ELISA, 21 of 36 preadsorbed BP sera showed positive results with relatively high OD450 values, whereas 19 sera showed positive reactivity after IgG adsorption (Fig. 2b , Table 1 and Table S2 ; see Supporting Information). In the IgE BP230 ELISA, 18 of 36 preadsorbed BP sera showed positive results with relatively lower OD450 values, whereas 15 sera showed positive reactivity after IgG adsorption (Fig. 2d , Table 1 and Table S2 ; see Supporting Information). We repeated the IgE BP180 ELISA for the 15 representative preadsorbed BP sera and were able to reproduce the results, confirming the reproducibility of all of the IgE ELISAs.
Validation of the results of IgG and IgE enzyme-linked immunosorbent assays by receiver operating characteristic curve and statistical analyses
The results of the ROC analyses showed high sensitivity and specificity of the IgG ELISA of BP180 for the diagnosis of BP [area under the curve (AUC) = 1Á0] ( Fig. S2a ; see Supporting Information), whereas the analyses of the IgG ELISA of BP230 were slightly lower (AUC = 0Á85) ( Fig. S2b ; see Supporting Information). These results confirmed the findings of previous studies reporting that the IgG ELISA of BP180 is a highly sensitive method for diagnosing BP, and that the IgG ELISA of BP230 is a valid supportive diagnostic method. 7, 8 The results of the ROC analyses showed lower sensitivity and specificity of the IgE ELISAs of both BP180 and BP230 for the diagnosis of BP (AUCs = 0Á59-0Á74) ( Fig. S2c-f ; see Supporting Information), compared with those of IgG ELISAs of either BP180 or BP230. As described above, preadsorbed and postadsorbed sera showed comparable results for either OD450 values or positive ratios in both BP180 and BP230 IgE ELISAs. The similarity of the results between preadsorbed and postadsorbed sera was also examined using ROC analyses and statistical analyses. Neither increases nor decreases of AUCs in preadsorbed and postadsorbed sera ROC analyses were found in the IgE ELISAs of both BP180 (Fig. S2b, c ; see Supporting Information) and BP230 ( Fig. S2e, f; see Supporting Information), indicating that the IgE ELISAs of both BP180 and BP230 had similar sensitivity or specificity in preadsorbed and postadsorbed sera.
Furthermore, statistical analyses of the IgE ELISAs of BP180 and BP230 also showed a strong positive correlation (P < 0Á001) between preadsorbed and postadsorbed sera ( Table 2) .
Precise and detailed analyses of the results of IgE enzyme-linked immunosorbent assays of both BP180 and BP230 in preadsorbed and postadsorbed sera Although the ROC and statistical analyses indicated similarity between preadsorbed and postadsorbed sera in the IgE ELISAs for both BP180 and BP230, detailed inspection of the results identified either a reduction or an increase in OD values for some of the individual BP sera.
We summarized the ratios of the increase or decrease in OD450 values after IgG adsorption compared with the preadsorbed values in both BP180 and BP230 ELISAs for IgE ELISApositive BP sera (Fig. 2e) . Briefly, OD450 values decreased to less than 60% in four BP sera and in three BP sera for BP180 and BP230, respectively, with one of each serum decreasing to less than 20%. Conversely, OD450 values increased to more than 120% in five BP sera and in two BP sera for BP180 and BP230, respectively, with one serum increasing to 286% in the BP230 ELISA. Positive reactivity for two preadsorbed BP sera and three preadsorbed BP sera became negative for BP180 and BP230, respectively, after IgG adsorption. No BP sera became positive after IgG adsorption for either BP180 or BP230.
The results of statistical analysis of enzyme-linked immunosorbent assays
The correlation among all ELISAs, i.e. IgG and IgE ELISAs of BP180 or BP230 for preadsorbed and postadsorbed BP sera, was statistically analysed (Table 2) .
In addition to the correlations between preadsorbed and postadsorbed sera in IgE ELISAs for both BP180 and BP230 described above, there were a number of pairs of ELISAs with significant positive or negative correlations (Table 2) . Notably, the negative correlations between preadsorbed and postadsorbed sera in IgG ELISAs for both BP180 and BP230 were apparent (Table 2) . We also found a significant positive correlation between IgG and IgE antibodies in both BP180 and BP230 ELISAs. In addition, a slight correlation was found between the IgG BP230 ELISA and the IgE BP180 ELISA.
Statistical analysis of the results of enzyme-linked immunosorbent assays and clinical features
With regard to the IgG ELISAs, almost all of the postadsorbed BP sera showed negative results in the BP230 ELISA, therefore we statistically analysed the other three ELISAs for an association with clinical parameters (statistically significant results in Table 2 , all results in Table S2 ; see Supporting Information).
We found a statistically significant association of indices of IgG BP180 ELISAs for both preadsorbed and postadsorbed BP sera with severity scores 1, whereas indices of IgG BP180 ELISA for only preadsorbed sera correlated with sex (higher indices in male patients) and eosinophils. However, no statistical significance was detected in the BP230 ELISAs. These results indicate that IgG anti-BP180 antibodies correlated with disease activity in BP. 7 For the IgE ELISAs, we found a statistically significant correlation of OD450 values in the IgE BP180 ELISAs for both preadsorbed and postadsorbed BP sera with severity scores 1 and 2, whereas no statistical significance was detected in the BP230 ELISA for both preadsorbed sera. These results indicate that IgE anti-BP180 antibodies also correlated with disease activity in BP.
As IgE antibodies have been suggested to play a role in inflammation, i.e. erythematous phenotype, we rigorously inspected the relationship between IgE ELISAs and BP phenotypes. However, we found no significant association of OD450 values with the erythematous phenotype (Table S2; see Supporting Information). Interestingly, IgE anti-BP230 autoantibodies in both preadsorbed and postadsorbed sera positively correlated to the nodular phenotype, whereas IgE anti-BP180 autoantibodies in both preadsorbed and postadsorbed sera negatively correlated to the nodular phenotype.
The statistical evaluation using a paired t-test revealed a significant positive correlation for total serum IgE with the ELISAs of both BP180 (P = 0Á0096) and BP230 (P = 0Á0095), indicating that BP sera with high total serum IgE tended to show positive reactivity in IgE ELISAs.
Discussion
In this study, in order to determine precisely the presence and the significance of IgE autoantibodies in BP, we established reliable IgE ELISAs for both BP180 and BP230.
In addition to an extreme excess in the ratio of IgG to IgE, previous IgG ELISAs for BP antigens and desmogleins showed plateaus in reactivity lines in BP and pemphigus, respectively, 7, 8, 36, 37 indicating that most patients' sera have equal or excess amounts of autoantibodies against antigenic epitopes on RPs coated on ELISA plates. Therefore, we were concerned that IgG autoantibodies mask all epitopes for IgE autoantibodies, leading to false-negative results in IgE ELISAs. Furthermore, ELISA plates used in this study were coated with small RP of BP180 NC16a domain (about 70aa) 7 and larger RP of BP230 N-terminal and C-terminal domains. 8 Thus, BP180 RP has a larger number of molecules with restricted but concentrated epitopes, whereas BP230 RP has a smaller number of molecules with various epitopes. These differences may also influence sensitivity and specificity in IgE ELISAs. For these reasons, in order to determine precisely and extensively the influence of excess amounts of IgG autoantibodies on the reactivity of IgE autoantibodies in IgE ELISAs, the first part of this study examined both preadsorbed and postadsorbed IgG samples prepared from all sera.
In general, preadsorbed and postadsorbed BP sera showed comparable results in both BP180 and BP230 ELISAs. Both ROC analyses and statistical analyses indicated consistent results between IgG preadsorbed and postadsorbed samples. Therefore, it may be preferable to use IgE ELISAs with preadsorbed serum samples in future studies, as the IgG adsorption procedure is time-consuming and avoiding this procedure can make IgE ELISA systems simpler.
However, the mechanisms for the sufficient reactivity of IgE with RPs on the ELISA plates are currently unknown. It is plausible that IgE antibodies have a much higher affinity to antigens than IgG antibodies, or that the ratio of IgG autoantibodies to the total IgG is very low (possibly only 0Á001%). Another possibility may be that the ratio of IgE autoantibodies to the total amount of IgE is much higher (possibly 10%). Alternatively, IgE autoantibodies may react with different epitopes from those that react with IgG autoantibodies. In this case, the epitopes for IgE antibodies should be sufficiently separated from those for IgG antibodies, so that the binding of IgG autoantibodies to IgG antibody-specific epitopes does not interfere with the binding of IgE autoantibodies to IgE antibody-specific epitopes.
Nevertheless, following a detailed inspection of our results, multiple sera showed significantly higher or lower OD values in IgE ELISAs after IgG adsorption. A decrease of OD450 values after IgG adsorption may indicate that the antihuman IgE monoclonal antibody used as a secondary antibody in our ELISAs cross-reacted with IgG in these sera. Although it is not known why such cross-reactivity occurred in particular BP sera, the anti-IgE secondary antibody had higher affinity with particular IgG subclasses, which were the major IgG subclasses for these BP sera.
Conversely, an increase in OD450 values after IgG adsorption may indicate that excess amounts of IgG autoantibodies interfered with IgE reactivity. It is not known why such interference was evident only in particular BP sera. One possibility is that those sera had very large amounts of IgG autoantibodies, although such a tendency was not detected in BP sera.
Therefore, to avoid these undesirable reactions, which may cause false-positive and false-negative results, future studies may require improved IgE ELISA methods, including the use of a secondary antibody more specific to IgE or the inclusion of an IgG adsorption procedure.
In our IgE ELISAs, 21 BP sera (58%) and 18 BP sera (50%) showed IgE autoantibodies to BP180 and BP230, respectively. These results are considered to be comparable to ratios found in previous studies (22-77%). [17] [18] [19] [20] [21] 24, 25, 27 In previous studies, details of the relationships between BP180 and BP230 or between IgG and IgE antibodies were not described. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Our statistical analyses of various pairs of ELISAs showed significant positive correlations between IgG and IgE autoantibodies to both BP180 and BP230. Indeed, all 36 BP sera showed positive results in the IgG BP180 ELISA, and all 18 positive sera in the IgE BP230 ELISA were also positive in the IgG BP230 ELISA. These results may suggest that the positive IgE reactivity in IgE ELISAs was caused by the cross-reactivity of the anti-IgE secondary antibody to IgG antibodies. However, this possibility could be excluded by the fact that some BP sera with very high index values in IgG ELISAs of BP180 and BP230 showed completely negative results in corresponding IgE ELISAs.
In the second part of this study, we examined the clinical features of patients with BP, particularly in terms of their relationship to the ELISA results. Clinical assessments revealed known BP characteristics, i.e. female predominance and slight increases in white blood cell counts, eosinophils counts and C-reactive protein. However, our patients were relatively young (mean age 63Á56 years), although the reason for this was unclear.
Indices in IgG BP180 ELISA antibodies statistically correlated with severity scores 1 and 2 and eosinophil counts. It is unclear why male patients showed higher indices in the IgG BP180 ELISA. Furthermore, OD450 values in the IgE BP180 ELISAs also correlated with severity scores 1 and 2. Therefore, both IgG and IgE BP180 ELISAs were considered to be helpful in determining disease activity in patients with BP. In contrast, no statistically significant relationships with clinical parameters were found in the BP230 ELISA for either IgG or IgE antibodies.
Although we expected to find a close relationship between IgE autoantibodies and the inflammatory BP phenotype, neither BP180 nor BP230 IgE ELISAs showed a significant association with clinical phenotypes, particularly erythematous or bullous/erythematous phenotypes. In contrast, interestingly, the IgE ELISA for BP230 showed a statistically significant association with the nodular phenotype, although the mechanism for this phenomenon requires further study.
Our statistical study indicated that BP sera with higher total serum IgE tended to be positive in IgE ELISAs, suggesting that total serum IgE may result in positivity in the IgE ELISAs. However, this possibility could be excluded by two findings in our study, i.e. the lack of a correlation between IgE ELISAs of BP180 and BP230, and the lack of positive reactivity in IgE ELISAs for atopic dermatitis sera with high total serum IgE.
In conclusion, we developed reliable novel IgE ELISAs for both BP180 and BP230, and showed that a significant number of BP sera had IgE autoantibodies. Our results indicated that IgE anti-BP180 antibodies correlated with disease activity in patients with BP, but not with BP phenotypes. Previous reports suggested that patients with BP with IgE autoantibodies are responsive to omalizumab. [28] [29] [30] Therefore, our ELISAs should be helpful for selecting patients with BP who may be suitable for omalizumab therapy. However, the relationship between IgE autoantibodies and inflammatory phenotype should be further investigated in future studies using a larger cohort of patients with BP.
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